RIN3 mutations impairing binding of the Alzheimer’s disease–associated protein BIN1 lead to RAB5 hyperactivation and endosomal pathology
Science Advances · 2026
DOI: 10.1126/sciadv.adx2127 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Anna K Maaser-Hecker und 9 weiteren Autor:innen. Beteiligte Einrichtung: Genetics and Aging Research Unit, McCance Center for Brain Health, Department of Neurology, MassGeneral Institute for Neurodegenerative Disease, Mass…. Hauptthemen laut MEDLINE: rab5 GTP-Binding Proteins, Endosomes, Alzheimer Disease, Adaptor Proteins, Signal Transducing. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, JPB Foundation, Cure Alzheimer's Fund.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer’s disease (AD) risk is strongly influenced by genetic variants that converge on pathways regulating endosomal homeostasis. Among these, BIN1 and RIN3 have emerged as susceptibility genes, yet their functional relationship in AD remains largely unknown. Here, we investigated how BIN1 and RIN3 interaction regulates RAB5 activity and endosomal pathology. RIN3 has been shown to bind BIN1, and we previously reported that this interaction modulates amyloid-β (Aβ) precursor protein (APP) trafficking and Aβ generation in vitro. To extend these findings, we used Rin3 constitutive knockout ( Rin3-CKO ) mice and CRISPR-Cas9–edited human induced pluripotent stem cell–derived neurons carrying either BIN1 knockout or rare familial AD RIN3 missense mutations within the BIN1-binding domain. We found that disruption of BIN1-RIN3 binding, through either genetic deletion or pathogenic RIN3 variants, resulted in RIN3-mediated RAB5 hyperactivation and enlargement of neuronal endosomes, a hallmark of early AD pathology. Transcriptomic profiling further revealed dysregulated expression of AD-related genes. Together, these findings establish BIN1 as a critical regulator of RIN3-driven RAB5 activation and neuronal endosomal homeostasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Genetics and Aging Research Unit, McCance Center for Brain Health, Department of Neurology, MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02…
- Department of Genetics and Genomics, Mydnavar, 28475 Greenfield Rd. STE 113 PMB 52423, Southfield, MI 48076, USA.
ORCID-Profile: Anna K Maaser-Hecker, Amit K Maiti, Se Hoon Choi, Dmitry Prokopenko, Rudolph E Tanzi, Raja Bhattacharyya
Förderung
- NINDS NIH HHS
- JPB Foundation
- Cure Alzheimer's Fund
- NIH
Zitieren
APA
Maaser-Hecker, A. K., Zellmer, J. C., Kim, M., Bakiasi, G., Maiti, A. K., Curtat, M. P. C., Choi, S. H., Prokopenko, D., Tanzi, R. E., & Bhattacharyya, R. (2026). RIN3 mutations impairing binding of the Alzheimer’s disease–associated protein BIN1 lead to RAB5 hyperactivation and endosomal pathology. Science Advances. https://doi.org/10.1126/sciadv.adx2127
Vancouver
Maaser-Hecker AK, Zellmer JC, Kim M, Bakiasi G, Maiti AK, Curtat MPC, et al. RIN3 mutations impairing binding of the Alzheimer’s disease–associated protein BIN1 lead to RAB5 hyperactivation and endosomal pathology. Science Advances. 2026. doi:10.1126/sciadv.adx2127
BibTeX
@article{MaaserHecker2026,
author = {Maaser-Hecker, Anna K and Zellmer, Jacob C and Kim, Michelle and Bakiasi, Grisilda and Maiti, Amit K and Curtat, Matea P C and Choi, Se Hoon and Prokopenko, Dmitry and Tanzi, Rudolph E and Bhattacharyya, Raja},
title = {RIN3 mutations impairing binding of the Alzheimer’s disease–associated protein BIN1 lead to RAB5 hyperactivation and endosomal pathology},
journal = {Science Advances},
year = {2026},
doi = {10.1126/sciadv.adx2127}
}
EUVIMED